Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine - Tập 385 Số 7 - Trang 585-594 - 2021
Jamie Lopez Bernal1, Nick Andrews1, Charlotte Gower1, Eileen Gallagher1, Ruth Simmons1, Simon Thelwall1, Julia Stowe1, Elise Tessier1, Natalie Groves1, Gavin Dabrera1, Richard Myers1, Colin Campbell1, Gayatri Amirthalingam1, Matt Edmunds1, Maria Zambon1, Kevin Brown1, Susan Hopkins1, Meera Chand1, Mary Ramsay1
1From Public Health England (J.L.B., N.A., C.G., E.G., R.S., S.T., J.S., E.T., N.G., G.D., R.M., C.N.J.C., G.A., M.E., M.Z., K.E.B., S.H., M.C., M.R.), the National Institute of Health Research (NIHR) Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine (J.L.B., N.A., C.N.J.C., G.A., K.E.B., M.R.), the NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London (J.L.B., M.Z.), and Guy's and St. Thomas' Hospital NHS Trust (M.C.), London, and Healthcare Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford (S.H.) - all in the United Kingdom.

Tóm tắt

Từ khóa


Tài liệu tham khảo

European Centre for Disease Prevention and Control. Threat assessment brief: emergence of SARS-CoV-2 B.1.617 variants in India and situation in the EU/EEA. May 11 2021 (https://www.ecdc.europa.eu/en/publications-data/threat-assessment-emergence-sars-cov-2-b1617-variants).

10.1056/NEJMe2107728

10.1002/gch2.1018

Public Health England. SARS-CoV-2 variants of concern and variants under investigation in England. Technical briefing 11. May 13 2021 (https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/986380/Variants_of_Concern_VOC_Technical_Briefing_11_England.pdf).

Joint Committee on Vaccination and Immunisation. Priority groups for coronavirus (COVID-19) vaccination: advice from the JCVI 30 December 2020. London: Department of Health and Social Care January 6 2021 (https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020).

Joint Committee on Vaccination and Immunisation. Optimising the COVID-19 vaccination programme for maximum short-term impact. Independent report. London: Department of Health and Social Care January 26 2021 (https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement/optimising-the-covid-19-vaccination-programme-for-maximum-short-term-impact).

10.1056/NEJMoa2034577

10.1016/S0140-6736(20)32661-1

10.1056/NEJMoa2035389

10.1136/bmj.n1088

10.1016/S0140-6736(21)00790-X

Shrotri M Krutikov M Palmer T et al. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities (VIVALDI study). March 26 2021 (https://www.medrxiv.org/content/10.1101/2021.03.26.21254391v1). preprint.

10.15585/mmwr.mm7013e3

10.1056/NEJMoa2101765

Vasileiou E Simpson CR Robertson C et al. Effectiveness of first dose of COVID-19 vaccines against hospital admissions in Scotland: national prospective cohort study of 5.4 million people. February 19 2021 (https://ssrn.com/abstract=3789264). preprint.

Hyams C Marlow R Maseko Z et al. Assessing the effectiveness of BNT162b2 and ChAdOx1nCoV-19 COVID-19 vaccination in prevention of hospitalisations in elderly and frail adults: a single centre test negative case-control study. March 3 2021 (https://ssrn.com/abstract=3796835). preprint.

10.1056/NEJMc2104974

10.1038/s41586-021-03398-2

10.1056/NEJMc2102017

10.1056/NEJMoa2103055

Parry HM Tut G Faustini S et al. BNT162b2 vaccination in people over 80 years of age induces strong humoral immune responses with cross neutralisation of P.1 Brazilian variant. March 31 2021 (https://ssrn.com/abstract=3816840). preprint.

Skowronski DM Setayeshgar S Zou M et al. Single-dose mRNA vaccine effectiveness against SARS-CoV-2 including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia Canada. June 9 2021 (https://www.medrxiv.org/content/10.1101/2021.06.07.21258332v1). preprint.

10.1016/j.cell.2020.07.012

Johnson BA Xie X Kalveram B et al. Furin cleavage site is key to SARS-CoV-2 pathogenesis. August 26 2020 (https://www.biorxiv.org/content/10.1101/2020.08.26.268854v1). preprint.

10.2807/1560-7917.ES.2020.25.32.2001483

Bull M Chand M Connor T et al. Standardised variant definitions. 2021 (https://github.com/phe-genomics/variant_definitions).

Ministry of Housing Communities and Local Government. English indices of deprivation 2019. September 26 2019 (https://www.gov.uk/government/statistics/english-indices-of-deprivation-2019).

NHS Digital. COVID-19 — high risk shielded patient list identification methodology: rule logic. 2020 (https://digital.nhs.uk/coronavirus/shielded-patient-list/methodology/rule-logic).

Care Quality Commission. CQC care directory. 2021 (https://www.cqc.org.uk/files/cqc-care-directory-zip).

Yadav PD Sapkal GN Abraham P et al. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. April 23 2021 (https://www.biorxiv.org/content/10.1101/2021.04.23.441101v1). preprint.

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 385 Số 7

585-594

Thông tin tác giả